News
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake.
In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
F.D.A. resignation: The Food and Drug Administration’s top vaccine and gene therapy official resigned on Tuesday after a ...
Desai believes it's a "good time for fixed income," but wants to see more realistic investor expectations. Generations out there in the past got accustomed to getting just 1% -2.5% for investing in 10 ...
Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping ...
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...
At least two people, including a New York City police officer, have been shot in Manhattan office building, a person familiar with the matter tells The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results